Back
Share
Orbimed
VC firmOrbiMed is a leading global healthcare investment firm focused on driving innovation in biopharmaceuticals, medical devices, diagnostics, and healthcare services. With over $17 billion in assets under management, they invest across all stages of company development, from early-stage to large multinational corporations.
Specification
Stages
3. Early Revenue
Target countries
Canada
USA
India
Israel
China
UK
Lead
N/A
Tickets
$50M to $100M
Location
601 Lexington Avenue (at 53rd Street), 54th Floor New York, NY 10022-4629, United States
Explore similar Venture Funds to Orbimed
Venrock is a venture capital firm with over 50 years of experience, focused on investing in early-stage technology, healthcare, and consumer compan...
Specification
Target countries
Canada
USA
Stages
2. Prototype
3. Early Revenue
First Round Capital is a venture capital firm that focuses on providing early-stage investments, particularly in pre-seed, seed, and Series A round...
Specification
Target countries
USA
Stages
2. Prototype
3. Early Revenue
We invest in tech entrepreneurs who are solving large problems with creative uses of AI/ML. We’re open to all AI applications, but these are the se...
Specification
Target countries
USA
Stages
1. Idea or Patent
2. Prototype
+ 1
Bitkraft Ventures is a San Francisco–based early to mid‑stage venture capital firm specializing in gaming, esports, interactive media, and Web3 sta...
Specification
Target countries
Europe
India
USA
Stages
2. Prototype
3. Early Revenue
+ 3
We invest early in European startups enabled by software, data, and new technologies across industries. To date, our initial investments have range...
Specification
Target countries
Sweden
Finland
Norway
Denmark
Germany
Estonia
Latvia
Lithuania
Portugal
Spain
France
Stages
1. Idea or Patent
2. Prototype
+ 1
Fortescue Capital, formerly known as the Foresight WAE Technology Fund, is a green energy investment accelerator platform established by Fortescue ...
Specification
Target countries
USA
UK
Australia
Stages
2. Prototype
3. Early Revenue